TED
Clinical trials for TED explained in plain language.
Never miss a new study
Get alerted when new TED trials appear
Sign up with your email to follow new studies for TED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to reduce bulging eyes in thyroid disease
Disease control OngoingThis Phase 3 trial tests satralizumab, a drug that blocks IL-6, in 131 people with moderate-to-severe thyroid eye disease. The main goal is to see if it reduces eye bulging by at least 2 mm after 24 weeks. Participants receive either satralizumab or placebo injections, and resear…
Matched conditions: TED
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug NTB003 enters first human safety tests
Knowledge-focused ENROLLING_BY_INVITATIONThis Phase 1 trial is testing a new drug called NTB003 in 40 healthy adults to see if it is safe and how the body processes it. Participants will receive either NTB003 or a placebo in increasing doses. The study is an early step toward possibly treating thyroid eye disease, but i…
Matched conditions: TED
Phase: PHASE1 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:57 UTC